The Discounted Cash Flow (DCF) valuation of Astellas Pharma Inc (4503.T) is 1,878.49 JPY. With the latest stock price at 2,657.50 JPY, the upside of Astellas Pharma Inc based on DCF is -29.3%.
Based on the latest price of 2,657.50 JPY and our DCF valuation, Astellas Pharma Inc (4503.T) is a sell. selling 4503.T stocks now will result in a potential gain of 29.3%.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 7.4% | 6.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 933.83 - 11,270.70 | 1,878.49 |
| Upside | -64.9% - 324.1% | -29.3% |